In the global race to curb the pandemic, scientists are testing a new kind of vaccine. Roger Highfield, Science Director, talks to key figures in the ‘David and Goliath’ race for a COVID-19 ‘RNA vaccine’.
Science Director Roger Highfield explores how growing human tissue into mini-organs, or ‘organoids’, will help the fight against COVID-19, from explaining puzzling complications to creating novel treatments.
The UK has analysed the genetic sequences of more SARS-CoV-2 viruses than any other country. Science Director Roger Highfield investigates how this and other data can help understand how to control the virus and ultimately save lives.
Sir Michael Marmot, Director of the Institute of Health Equity at University College London, talks to Science Director Roger Highfield about why some communities are at higher risk of COVID-19.
Share your #MaskSelfie with us and help document the coronavirus pandemic for future generations
Roger Highfield discusses the risks posed by the COVID-19 pandemic, both real and perceived, with Dr Sander van der Linden.
The body’s protective immune system holds the key to diagnosing, treating and vaccinating against coronavirus. Science Director, Roger Highfield, focuses on antibodies.
The development of COVID-19 treatments, tests, drugs and vaccines will be accelerated by molecular understanding of the COVID-19 virus. Roger Highfield, Science Director, looks at what is happening in Britain’s most prestigious molecular biology laboratory.
Roger Highfield, Science Director, on why the fate of the nation rests on R, the ‘reproduction number’, and a novel ‘stringency index’ that compares the pandemic responses of 160 nations.
Roger Highfield, Science Director, discusses how digital technologies can curb COVID-19 with Hannah Fry, who conducted a prescient simulation of a UK outbreak, and Dr Alice Tan of MizMedi Women’s Hospital, who explains why South Korea’s death toll is relatively low.